Cosmo Pharmaceuticals N.V. (SWX:COPN)
91.40
+2.40 (2.70%)
At close: Dec 5, 2025
Cosmo Pharmaceuticals Employees
Cosmo Pharmaceuticals had 322 employees as of December 31, 2024. The number of employees decreased by 3 or -0.98% compared to the previous year.
Employees
322
Change (1Y)
-3
Growth (1Y)
-0.98%
Revenue / Employee
512.76K CHF
Profits / Employee
168.77K CHF
Market Cap
1.46B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Galderma Group AG | 6,545 |
| Alcon | 25,599 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
Cosmo Pharmaceuticals News
- 3 days ago - Cosmo Pharmaceuticals (CMOPF) Stock Soars on Promising Hair Loss Treatment Results - GuruFocus
- 4 days ago - EU Grants Marketing Authorization For Winlevi Cream - Nasdaq
- 6 weeks ago - EU Approves Cosmo Pharma' Winlevi For Acne Treatment In Adults And Adolescents - Nasdaq
- 3 months ago - Winlevi Acne Cream Secures EU Drug Panel Support in Reversal for Cosmo - Financial Post
- 8 months ago - Cosmo Pharmaceuticals ernennt neuen Chief Legal Counsel - Cash
- 9 months ago - Cosmo Pharmaceuticals reports FY results - Seeking Alpha
- 9 months ago - Cosmo Pharmaceuticals NV (CMOPF) (FY 2024) Earnings Call Highlights: Record Revenues and ... - GuruFocus
- 9 months ago - Full Year 2024 Cosmo Pharmaceuticals NV Earnings Call Transcript - GuruFocus